title: More drug studies need to include pregnant women, says bulletin.
authors.forename: Zosia
authors.initials: Z
authors.lastname: Kmietowicz
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000592:standards* / Q000639:trends*; D004345:Drug Industry; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D009026:Mortality / Q000639:trends; D009765:Obesity / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000401:mortality*; D037841:Pregnant People; D012107:Research Design / Q000592:standards / Q000639:trends; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects; D006113:United Kingdom / Q000453:epidemiology; D014635:Valproic Acid / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D013723:Teratogens; D013792:Thalidomide; D014635:Valproic Acid